Haryana drug controller accused of taking Rs 5 crore bribe from Maiden Pharma

Published On 2023-06-16 09:43 GMT   |   Update On 2024-01-19 10:55 GMT

Indian authorities have launched an inquiry into an allegation that a local pharmaceutical regulator, in return for a bribe, helped switch samples of cough syrups that the World Health Organization (WHO) had linked to the deaths of children in Gambia before the samples were tested at an Indian laboratory, according to two government officials and documents reviewed by Reuters.In an April 29...

Login or Register to read the full article

 Indian authorities have launched an inquiry into an allegation that a local pharmaceutical regulator, in return for a bribe, helped switch samples of cough syrups that the World Health Organization (WHO) had linked to the deaths of children in Gambia before the samples were tested at an Indian laboratory, according to two government officials and documents reviewed by Reuters.

In an April 29 letter to the Anti-Corruption Bureau (ACB) in Haryana reviewed by Reuters, a lawyer named Yashpal accused the state's drug controller, Manmohan Taneja, of taking a bribe of Rs 50 million ($605,419) from local manufacturer Maiden Pharmaceuticals to help it switch the samples before an Indian government laboratory tested them. Maiden's factory is based in Haryana state.

For more details, check out the full story on the link below:

Haryana Drug Controller Accused Of Taking Rs 5 Crore Bribe From Maiden Pharma, Inquiry Launched




Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News